Growth Metrics

Merck (MRK) Assets Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.78%
Dec 31, 2025 16.87%
Sep 30, 2025 10.22%
Jun 30, 2025 4.34%
Mar 31, 2025 8.76%
Dec 31, 2024 9.78%
Sep 30, 2024 10.12%
Jun 30, 2024 7.81%
Mar 31, 2024 -1.81%
Dec 31, 2023 -2.28%
Sep 30, 2023 -0.33%
Jun 30, 2023 -2.45%
Mar 31, 2023 1.06%
Dec 31, 2022 3.28%
Sep 30, 2022 14.53%
Jun 30, 2022 18.09%
Mar 31, 2022 17.41%
Dec 31, 2021 15.40%
Sep 30, 2021 4.11%
Jun 30, 2021 0.08%
Mar 31, 2021 6.99%
Dec 31, 2020 8.52%
Sep 30, 2020 7.76%
Jun 30, 2020 7.92%
Mar 31, 2020 3.11%
Dec 31, 2019 2.13%
Sep 30, 2019 -2.11%
Jun 30, 2019 -1.26%
Mar 31, 2019 -4.29%
Dec 31, 2018 -5.96%
Sep 30, 2018 -7.14%
Jun 30, 2018 -8.37%
Mar 31, 2018 -10.89%
Dec 31, 2017 -7.87%
Sep 30, 2017 -6.77%
Jun 30, 2017 -3.81%
Mar 31, 2017 -2.22%
Dec 31, 2016 -6.20%
Sep 30, 2016 -2.86%
Jun 30, 2016 -5.95%
Mar 31, 2016 -8.85%
Dec 31, 2015 3.58%
Sep 30, 2015 -0.57%
Jun 30, 2015 4.83%
Mar 31, 2015 -0.11%
Dec 31, 2014 -7.08%
Sep 30, 2014 -4.33%
Jun 30, 2014 -8.44%
Dec 31, 2013 -0.46%
Jun 30, 2013 1.28%
Dec 31, 2012 0.96%
Jun 30, 2012 -0.63%
Mar 31, 2012 -0.34%
Dec 31, 2011 -0.62%
Sep 30, 2011 -1.21%
Jun 30, 2011 0.02%
Mar 31, 2011 -5.13%
Dec 31, 2010 -5.82%
Sep 30, 2010 253.03%
Jun 30, 2010 259.35%